| 1 |
Chen Z, Lv Y. Uninterrupted dynamic stiffening microenvironment enhances the paracrine function of mesenchymal stem cells for vascularization through chromatin remodeling. Materials & Design 2022;224:111328. [DOI: 10.1016/j.matdes.2022.111328] [Reference Citation Analysis]
|
| 2 |
Gao Z, Wang N, Liu X. Human placenta mesenchymal stem cell-derived exosome shuttling microRNA-130b-3p from gestational diabetes mellitus patients targets ICAM-1 and perturbs human umbilical vein endothelial cell angiogenesis. Acta Diabetol 2022;59:1091-107. [PMID: 35676597 DOI: 10.1007/s00592-022-01910-2] [Reference Citation Analysis]
|
| 3 |
Yang C, Pan J, Luo X, Li J, Jiang Z. Hypoxia-induced mesenchymal stem cells inhibit corneal fibroblast proliferation by regulating the WWP2/Notch1 axis. Regen Med 2022. [PMID: 35545948 DOI: 10.2217/rme-2021-0173] [Reference Citation Analysis]
|
| 4 |
Zhou F, Dai O, Peng C, Xiong L, Ao H, Liu F, Zhou QM. Pro-Angiogenic Effects of Essential Oil from Perilla frutescens and Its Main Component (Perillaldehyde) on Zebrafish Embryos and Human Umbilical Vein Endothelial Cells. Drug Des Devel Ther 2021;15:4985-99. [PMID: 34924753 DOI: 10.2147/DDDT.S336826] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 5 |
Calonge M, Nieto-Miguel T, de la Mata A, Galindo S, Herreras JM, López-Paniagua M. Goals and Challenges of Stem Cell-Based Therapy for Corneal Blindness Due to Limbal Deficiency. Pharmaceutics 2021;13:1483. [PMID: 34575560 DOI: 10.3390/pharmaceutics13091483] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 6 |
Pan J, Luo X, Zhao S, Li J, Jiang Z. miR-340-5p mediates the therapeutic effect of mesenchymal stem cells on corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 2021. [PMID: 34495369 DOI: 10.1007/s00417-021-05394-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 7 |
Ernst LM, Mithal LB, Mestan K, Wang V, Mangold KA, Freedman A, Das S. Umbilical cord miRNAs to predict neonatal early onset sepsis. PLoS One 2021;16:e0249548. [PMID: 33961620 DOI: 10.1371/journal.pone.0249548] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 8 |
Aravindhan S, Ejam SS, Lafta MH, Markov A, Yumashev AV, Ahmadi M. Mesenchymal stem cells and cancer therapy: insights into targeting the tumour vasculature. Cancer Cell Int 2021;21:158. [PMID: 33685452 DOI: 10.1186/s12935-021-01836-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 9 |
Galindo S, de la Mata A, López-Paniagua M, Herreras JM, Pérez I, Calonge M, Nieto-Miguel T. Subconjunctival injection of mesenchymal stem cells for corneal failure due to limbal stem cell deficiency: state of the art. Stem Cell Res Ther 2021;12:60. [PMID: 33441175 DOI: 10.1186/s13287-020-02129-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 10 |
Zhou F, Liu F, Liu J, He Y, Zhou Q, Guo L, Peng C, Xiong L. Stachydrine promotes angiogenesis by regulating the VEGFR2/MEK/ERK and mitochondrial-mediated apoptosis signaling pathways in human umbilical vein endothelial cells. Biomedicine & Pharmacotherapy 2020;131:110724. [DOI: 10.1016/j.biopha.2020.110724] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 11 |
Javan MR, Khosrojerdi A, Moazzeni SM. New Insights Into Implementation of Mesenchymal Stem Cells in Cancer Therapy: Prospects for Anti-angiogenesis Treatment. Front Oncol. 2019;9:840. [PMID: 31555593 DOI: 10.3389/fonc.2019.00840] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
|
